Trial Profile
Open labelled multicenter randomized comparative trial of high-dose toremifene for non-steroidal aromatase inhibitor resistant breast cancer compared to exemestane.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 09 Apr 2014
Price :
$35
*
At a glance
- Drugs Toremifene (Primary) ; Exemestane
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 15 Sep 2012 Results presented at the 2012 Breast Cancer Symposium.
- 15 Sep 2012 Status changed from active, no longer recruiting to completed, based on presentation of results.
- 06 May 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.